Molecular recognition of p53 and MDM2 by USP7/HAUSP.
Abstract
The ubiquitin-specific protease, USP7, has key roles in the p53 pathway whereby it stabilizes both p53 and MDM2. We show that the N-terminal domain of USP7 binds two closely spaced 4-residue sites in both p53 and MDM2, falling between p53 residues 359-367 and MDM2 residues 147-159. Cocrystal structures with USP7 were determined for both p53 peptides and for one MDM2 peptide. These peptides bind the same surface of USP7 as Epstein-Barr nuclear antigen-1, explaining the competitive nature of the interactions. The structures and mutagenesis data indicate a preference for a P/AXXS motif in peptides that bind USP7. Contacts made by serine are identical and crucial for all peptides, and Trp165 in the peptide-binding pocket of USP7 is also crucial. These results help to elucidate the mechanism of substrate recognition by USP7 and the regulation of the p53 pathway.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
USP7 TRAF-like domain residues D164 and W165 form essential contacts with P/A/ExxS motifs shared by all TRAF-like domain-binding substrates.
“The TRAF-like domain assumes an eight stranded antiparallel β- sandwich fold, with residues D164 and W165 forming essential contacts with P/A/ExxS motifs shared by all TRAF-like domain-binding substrates.”
From USP7 Is a Master Regulator of Genome Stability (2020) · cites this paper as Sheng et al., 2006
Mdm2 binds the USP7 TRAF-like domain with higher affinity than p53 because Mdm2 makes more extensive contacts.
“An obstacle to this switch is that while USP7 binds both Mdm2 and p53 via its TRAF-like domain, Mdm2 makes more extensive contacts and thus binds the TRAF-like domain with a higher affinity (Hu et al., 2006; Sheng et al., 2006).”
From USP7 Is a Master Regulator of Genome Stability (2020) · cites this paper as Sheng et al., 2006
USP7 has a central role in stabilizing p53 protein levels in response to genomic stress.
“As discussed in previous sections, USP7 has a central role in stabilizing p53 protein levels in response to genomic stress (Sheng et al., 2006).”
From USP7 Is a Master Regulator of Genome Stability (2020) · cites this paper as Sheng et al., 2006
Mdm2 seems to be a better binding partner of HAUSP than p53.
“Mdm2 seems to be a better binding partner of HAUSP than p53”
From USP10 Regulates p53 Localization and Stability by Deubiquitinating p53 (2010) · cites this paper as Sheng et al., 2006
Cites
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475 · see citing works
The PyMOL Molecular Graphics System
DeLano, W. L. (2002) · Medical Entomology and Zoology · Cited by 18,147 · see citing works
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse‐Kunstleve, R. W., Jiang, J., Kuszewski, J. J., Nilges, M., Pannu, N., et al. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998003254 · Cited by 15,720 · see citing works
Jones, T. A., Zou, J.-Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,650 · see citing works
A marker for Stevens–Johnson syndrome
Chung, W., Chung, W., Hong, H., Hsih, M., Yang, L., Ho, H., Wu, J., & Chen, Y.-T. (2004) · Nature · doi:10.1038/428486a · Cited by 1,748 · see citing works
Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization
Li, M., Chen, D., Shiloh, A., Luo, J., Nikolaev, A. Y., Qin, J., & Gu, W. J. (2002) · Nature · doi:10.1038/nature737 · Cited by 1,027 · see citing works
A dynamic role of HAUSP in the p53-Mdm2 pathway
Li, M., Brooks, C. L., Kon, N., & Gu, W. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00157-1 · Cited by 679 · see citing works
Distinct molecular mechanism for initiating TRAF6 signalling
Ye, H., Arron, J. R., Lamothe, B., Cirilli, M., Kobayashi, T., Shevde, N. K., Segal, D., Dzivenu, O. K., Vologodskaia, M., Yim, M., et al. (2002) · Nature · doi:10.1038/nature00888 · Cited by 665 · see citing works
Hu, M., Li, P., Li, M., Li, W., Yao, T., Wu, J.-W., Gu, W. J., Cohen, R. E., & Shi, Y. (2002) · Cell · doi:10.1016/s0092-8674(02)01199-6 · Cited by 648 · see citing works
Everett, R. D., Meredith, M., Orr, A., Cross, A., Kathoria, M., & Parkinson, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.7.1519 · Cited by 491 · see citing works
Multiple C-Terminal Lysine Residues Target p53 for Ubiquitin-Proteasome-Mediated Degradation
Rodríguez, M. S., Desterro, J. M. P., Laı́n, S., Lane, D. P., & Hay, R. T. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.22.8458-8467.2000 · Cited by 386 · see citing works
Disruption of HAUSP gene stabilizes p53.
Cummins, J. M., Rago, C., Kohli, M., Kinzler, K. W., Lengauer, C., & Vogelstein, B. (2004) · Nature · doi:10.1038/nature02501 · Cited by 379 · see citing works
Structure of the p53 Binding Domain of HAUSP/USP7 Bound to Epstein-Barr Nuclear Antigen 1
Saridakis, V., Sheng, Y., Sarkari, F., Holowaty, M. N., Shire, K., Nguyen, T., Zhang, R. G., Liao, J. C. C., Lee, W., Edwards, A. M., et al. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.02.029 · Cited by 362 · see citing works
Self-citationThe Structural Basis for the Recognition of Diverse Receptor Sequences by TRAF2
Ye, H., Park, Y. C., Kreishman, M., Kieff, E. D., & Wu, H. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80334-2 · Cited by 292 · see citing works
Meulmeester, E., Maurice, M. M., Boutell, C., Teunisse, A. F. A. S., Ovaa, H., Abraham, T. E., Dirks, R. W., & Jochemsen, A. G. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.04.024 · Cited by 260 · see citing works
Holowaty, M. N., Zeghouf, M., Wu, H., Tellam, J., Athanasopoulos, V., Greenblatt, J., & Frappier, L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303977200 · Cited by 228 · see citing works
Self-citationHAUSP is Required for p53 Destabilization
Cummins, J. M., & Vogelstein, B. (2004) · Cell Cycle · doi:10.4161/cc.3.6.924 · Cited by 188 · see citing works
Protein Interaction Domains of the Ubiquitin-specific Protease, USP7/HAUSP
Holowaty, M. N., Sheng, Y., Nguyen, T., Arrowsmith, C. H., & Frappier, L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307200200 · Cited by 182 · see citing works
Self-citationMeredith, M., Orr, A., & Everett, R. D. (1994) · Virology · doi:10.1006/viro.1994.1209 · Cited by 85 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes.
Reyes-Turcu, F. E., Ventii, K. H., & Wilkinson, K. D. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.082307.091526 · Cited by 1,396 · see citing works
Structural Biology of the Tumor Suppressor p53
Joerger, A. C., & Fersht, A. R. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.060806.091238 · Cited by 699 · see citing works
USP10 Regulates p53 Localization and Stability by Deubiquitinating p53
Yuan, J., Luo, K., Zhang, L., Cheville, J. C., & Lou, Z. (2010) · Cell · doi:10.1016/j.cell.2009.12.032 · Cited by 637 · see citing works
“In fact, Mdm2 seems to be a better binding partner of HAUSP than p53 (Hu et al., 2006; Sheng et al., 2006).”
Tumour suppression by p53: a role for the DNA damage response?
Meek, D. W. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2716 · Cited by 604 · see citing works
The role of ubiquitination and deubiquitination in cancer metabolism
Sun, T., Liu, Z., & Yang, Q. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01262-x · Cited by 518 · see citing works
Roey, K. V., Uyar, B., Weatheritt, R. J., Dinkel, H., Seiler, M., Budd, A., Gibson, T. J., & Davey, N. E. (2014) · Chemical Reviews · doi:10.1021/cr400585q · Cited by 496 · see citing works
How viruses hijack cell regulation
Davey, N. E., Travé, G., & Gibson, T. J. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.10.002 · Cited by 383 · see citing works
Deubiquitinating enzymes (DUBs): Regulation, homeostasis, and oxidative stress response
Snyder, N. A., & Silva, G. M. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101077 · Cited by 352 · see citing works
The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2
Stevenson, L. F., Sparks, A., Allende‐Vega, N., Xirodimas, D. P., Lane, D. P., & Saville, M. K. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601567 · Cited by 280 · see citing works
MDM2 and MDM4: p53 regulators as targets in anticancer therapy
Toledo, F., & Wahl, G. M. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.03.022 · Cited by 261 · see citing works
Faesen, A. C., Dirac, A. M. G., Shanmugham, A., Ovaa, H., Anastassis Perrakis, A., & Sixma, T. K. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.06.034 · Cited by 251 · see citing works
Epigenetic regulation of ferroptosis by H2B monoubiquitination and p53
Wang, Y., Yang, L., Zhang, X., Cui, W., Liu, Y., Sun, Q., He, Q., Zhao, S., Zhang, G., Wang, Y., et al. (2019) · EMBO Reports · doi:10.15252/embr.201847563 · Cited by 215 · see citing works
Structural Basis of Ubiquitin Recognition by the Deubiquitinating Protease USP2
Renatus, M., Gil-Parrado, S., D'Arcy, A., Eidhoff, U., Gerhartz, B., Hassiepen, U., Pierrat, B., Riedl, R., Vinzenz, D., Worpenberg, S., et al. (2006) · Structure · doi:10.1016/j.str.2006.06.012 · Cited by 212 · see citing works
Hao, Y.-H., Fountain, M. D., Fon Tacer, K., Xia, F., Bi, W., Kang, S.-H. L., Patel, A., Rosenfeld, J. A., Le Caignec, C., Isidor, B., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.07.033 · Cited by 206 · see citing works
Pal, A., Young, M. A., & Donato, N. J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1211 · Cited by 198 · see citing works
Uversky, V. N. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111874 · Cited by 193 · see citing works
USP7: Structure, substrate specificity, and inhibition
Pozhidaeva, A., & Bezsonova, I. (2019) · DNA Repair · doi:10.1016/j.dnarep.2019.02.005 · Cited by 178 · see citing works
USP37 directly deubiquitinates and stabilizes c-Myc in lung cancer
Pan, J., Deng, Q., Jiang, C., Wang, X., Niu, T., Li, H., Chen, T., Jin, J., Pan, W., Cai, X., et al. (2014) · Oncogene · doi:10.1038/onc.2014.327 · Cited by 169 · see citing works
Novellasdemunt, L., Foglizzo, V., Gómez-Cuadrado, L., Antas, P., Kucharska, A., Encheva, V., Snijders, A. P., & Li, V. S. W. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.072 · Cited by 163 · see citing works
Qi, S., Cheng, G., Cheng, X., Xu, Z., Xu, B., Zhang, W., & Qin, J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00233 · Cited by 162 · see citing works
Mittler, G., Butter, F., & Mann, M. (2008) · Genome Research · doi:10.1101/gr.081711.108 · Cited by 162 · see citing works
Deubiquitylase HAUSP stabilizes REST and promotes maintenance of neural progenitor cells
Huang, Z., Wu, Q., Guryanova, O. A., Cheng, L., Shou, W., Rich, J. N., & Bao, S. (2011) · Nature Cell Biology · doi:10.1038/ncb2153 · Cited by 160 · see citing works
TRIM37 controls cancer-specific vulnerability to PLK4 inhibition
Meitinger, F., Ohta, M., Lee, K.-Y., Watanabe, S., Davis, R. L., Anzola, J. V., Kabeche, R., Jenkins, D. A., Shiau, A. K., Desai, A. B., et al. (2020) · Nature · doi:10.1038/s41586-020-2710-1 · Cited by 155 · see citing works
Sivachandran, N., Sarkari, F., & Frappier, L. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000170 · Cited by 153 · see citing works
Self-citationEpstein–Barr Virus History and Pathogenesis
Yu, H., & Robertson, E. S. (2023) · Viruses · doi:10.3390/v15030714 · Cited by 152 · see citing works
HSV ICP0 recruits USP7 to modulate TLR-mediated innate response
Daubeuf, S., Singh, D., Tan, Y., Liu, H., Federoff, H. J., Bowers, W. J., & Tolba, K. A. (2008) · Blood · doi:10.1182/blood-2008-07-168203 · Cited by 146 · see citing works
The p53–Mdm2–HAUSP complex is involved in p53 stabilization by HAUSP
Brooks, C. L., Li, M., Hu, M., Shi, Y., & Gu, W. (2007) · Oncogene · doi:10.1038/sj.onc.1210531 · Cited by 144 · see citing works
Deubiquitinases and the new therapeutic opportunities offered to cancer
Pfoh, R., Lacdao, I. K., & Saridakis, V. (2015) · Endocrine Related Cancer · doi:10.1530/erc-14-0516 · Cited by 140 · see citing works
Self-citationWang, Z., Kang, W.-T., Li, O., Qi, F., Wang, J., You, Y., He, P., Suo, Z., Zheng, Y., & Liu, H. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.11.005 · Cited by 139 · see citing works
From Bortezomib to other Inhibitors of the Proteasome and Beyond
Buac, D., Shen, M., Schmitt, S. M., Kona, F. R., Deshmukh, R. R., Zhang, Z., Neslund-Dudas, C. M., Mitra, B., & Dou, Q. P. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319220012 · Cited by 138 · see citing works
Wood, V. H. J., O’Neil, J. D., Wei, W., Stewart, S. E., Dawson, W. O., & Young, L. S. (2007) · Oncogene · doi:10.1038/sj.onc.1210496 · Cited by 136 · see citing works
USP7 inhibits Wnt/β-catenin signaling through promoting stabilization of Axin
Ji, L., Lu, B., Zamponi, R., Charlat, O., Aversa, R. J., Yang, Z., Sigoillot, F. D., Zhu, X., Hu, T., Reece-Hoyes, J. S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12143-3 · Cited by 129 · see citing works
NMR as a “Gold Standard” Method in Drug Design and Discovery
Emwas, A.-H. M., Szczepski, K., Poulson, B. G., Chandra, K., McKay, R. T., Dhahri, M., Alahmari, F., Jaremko, Ł., Lachowicz, J. I., & Jaremko, M. (2020) · Molecules · doi:10.3390/molecules25204597 · Cited by 129 · see citing works
Sahtoe, D. D., & Sixma, T. K. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.05.002 · Cited by 127 · see citing works
Contributions of Epstein–Barr Nuclear Antigen 1 (EBNA1) to Cell Immortalization and Survival
Frappier, L. (2012) · Viruses · doi:10.3390/v4091537 · Cited by 127 · see citing works
Self-citationUSP7: Novel Drug Target in Cancer Therapy
Wang, Z., Kang, W.-T., You, Y., Pang, J., Ren, H., Suo, Z., Liu, H., & Zheng, Y. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00427 · Cited by 124 · see citing works
The Involvement of Ubiquitination Machinery in Cell Cycle Regulation and Cancer Progression
Zou, T., & Lin, Z. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115754 · Cited by 120 · see citing works
USP7 Is a Master Regulator of Genome Stability
Valles, G. J., Bezsonova, I., Woodgate, R., & Ashton, N. W. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00717 · Cited by 114 · see citing works
“An obstacle to this switch is that while USP7 binds both Mdm2 and p53 via its TRAF-like domain, Mdm2 makes more extensive contacts and thus binds the TRAF-like domain with a higher affinity (Hu et al., 2006; Sheng et al., 2006).”
BackgroundInfluentialp53 stability is regulated by diverse deubiquitinating enzymes
Kwon, S., Saindane, M., & Baek, K. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.08.001 · Cited by 110 · see citing works
Molecular understanding of USP7 substrate recognition and c-terminal activation.
Rougé, L., Bainbridge, T. W., Kwok, M., Tong, R., Di Lello, P., Wertz, I. E., Maurer, T., Ernst, J. A., & Murray, J. (2016) · Structure · doi:10.1016/j.str.2016.05.020 · Cited by 108 · see citing works
Modulation of the p53/MDM2 interplay by HAUSP inhibitors
Tavana, O., & Gu, W. J. (2016) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjw049 · Cited by 108 · see citing works
The emerging role of deubiquitinating enzymes in genomic integrity, diseases, and therapeutics
He, M., Zhou, Z., Shah, A. A., Zou, H., Tao, J., Chen, Q., & Wan, Y. (2016) · Cell & Bioscience · doi:10.1186/s13578-016-0127-1 · Cited by 106 · see citing works
DUBs, the regulation of cell identity and disease
Heideker, J., & Wertz, I. E. (2014) · Biochemical Journal · doi:10.1042/bj20140496 · Cited by 100 · see citing works
Reverse the curse—the role of deubiquitination in cell cycle control
Song, L., & Rapé, M. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.01.012 · Cited by 100 · see citing works
Fåhræus, R., & Olivares‐Illana, V. (2013) · Oncogene · doi:10.1038/onc.2013.410 · Cited by 97 · see citing works
The Epstein-Barr Virus EBNA1 Protein
Frappier, L. (2012) · Scientifica · doi:10.6064/2012/438204 · Cited by 97 · see citing works
Self-citationNathan, J. A., Sengupta, S., Wood, S. A., Admon, A., Markson, G., Sanderson, C. M., & Lehner, P. J. (2008) · Traffic · doi:10.1111/j.1600-0854.2008.00747.x · Cited by 97 · see citing works
Fernández‐Montalván, A., Bouwmeester, T., Joberty, G., Mader, R., Mahnke, M., Pierrat, B., Schlaeppi, J., Worpenberg, S., & Gerhartz, B. (2007) · The FEBS Journal · doi:10.1111/j.1742-4658.2007.05952.x · Cited by 96 · see citing works
Regulation of USP7: A High Incidence of E3 Complexes
Kim, R. Q., & Sixma, T. K. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.05.028 · Cited by 96 · see citing works
Ubiquitin-Specific Proteases: Players in Cancer Cellular Processes
Cruz, L. L., Soares, P., & Correia, M. (2021) · Pharmaceuticals · doi:10.3390/ph14090848 · Cited by 96 · see citing works
Differential Roles of ATM- and Chk2-Mediated Phosphorylations of Hdmx in Response to DNA Damage
Pereg, Y., Lam, S., Teunisse, A., Biton, S., Meulmeester, E., Mittelman, L., Buscemi, G., Okamoto, K., Taya, Y., Shiloh, Y., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00562-06 · Cited by 93 · see citing works
Wilson, J. B., Manet, É., Gruffat, H., Busson, P., Blondel, M., & Fåhræus, R. (2018) · Cancers · doi:10.3390/cancers10040109 · Cited by 93 · see citing works
The emerging nature of Ubiquitin-specific protease 7 (USP7): a new target in cancer therapy
Nininahazwe, L., Liu, B., He, C., Zhang, H., & Chen, Z. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.10.028 · Cited by 92 · see citing works
Role of EBNA1 in NPC tumourigenesis
Frappier, L. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.12.002 · Cited by 91 · see citing works
Self-citationPhylogeny of the TRAF/MATH Domain
Zapata, J. M., Martínez-García, V., & Lefebvre, S. (2007) · Springer eBooks · doi:10.1007/978-0-387-70630-6_1 · Cited by 88 · see citing works
Ouyang, L., Yan, B., Liu, Y., Mao, C., Wang, M., Liu, N., Wang, Z., Liu, S., Shi, Y., Chen, L., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0181-3 · Cited by 87 · see citing works
Delineating Crosstalk Mechanisms of the Ubiquitin Proteasome System That Regulate Apoptosis
Gupta, I., Singh, K., Varshney, N. K., & Khan, S. M. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00011 · Cited by 86 · see citing works
Deubiquitylating enzymes and disease
Singhal, S., Taylor, M. C., & Baker, R. T. (2008) · BMC Biochemistry · doi:10.1186/1471-2091-9-s1-s3 · Cited by 85 · see citing works
Zhao, G., Lin, Z., Lu, C., Gu, J., Yuan, Y., Xu, F., Liu, R., Ge, D., & Ding, J. (2014) · Tumor Biology · doi:10.1007/s13277-014-2773-4 · Cited by 84 · see citing works
TGF-β upregulates the translation of USP15 via the PI3K/AKT pathway to promote p53 stability
Liu, W.-T., Huang, K.-Y., Lu, M., Huang, H.-L., Chen, C.-Y., Cheng, Y.-L., Yu, H.-C., Liu, S.-Q., Lai, N.-S., & Huang, H.-B. (2016) · Oncogene · doi:10.1038/onc.2016.424 · Cited by 84 · see citing works
Deubiquitination of Tip60 by USP7 determines the activity of the p53-dependent apoptotic pathway.
Dar, A., Shibata, E., & Dutta, A. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00358-13 · Cited by 83 · see citing works
Discovery of Small Molecule CD40–TRAF6 Inhibitors
Zarzycka, B. A., Seijkens, T. T. P., Nabuurs, S. B., Ritschel, T., Grommes, J., Soehnlein, O., Schrijver, R., van Tiel, C. M., Hackeng, T. M., Weber, C., et al. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/ci500631e · Cited by 82 · see citing works
Molecular Mechanisms of DUBs Regulation in Signaling and Disease
Li, Y., & Reverter, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22030986 · Cited by 82 · see citing works
Bilateral inhibition of HAUSP deubiquitinase by a viral interferon regulatory factor protein
Lee, H.-R., Choi, W., Lee, S., Hwang, J., Hwang, E., Guchhait, K., Haas, J., Tóth, Z., Jeon, Y. H., Oh, T.-K., et al. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2142 · Cited by 81 · see citing works
Cao, J. Y., Mansouri, S., & Frappier, L. (2011) · Journal of Virology · doi:10.1128/jvi.05648-11 · Cited by 79 · see citing works
Self-citationFrappier, L. (2015) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-22834-1_1 · Cited by 78 · see citing works
Self-citationUSP7 is essential for maintaining Rad18 stability and DNA damage tolerance.
Zlatanou, A., Sabbioneda, S., Miller, E. S., Greenwalt, A., Aggathanggelou, A., Maurice, M. M., Lehmann, A. R., Stankovic, T., Reverdy, C., Colland, F., et al. (2016) · Oncogene · doi:10.1038/onc.2015.149 · Cited by 77 · see citing works
USP17 Regulates Ras Activation and Cell Proliferation by Blocking RCE1 Activity
Burrows, J. F., Kelvin, A. A., McFarlane, C., Burden, R. E., McGrattan, M. J., de la Vega, M., Govender, U., Quinn, D. J., Dib, K., Gadina, M., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807216200 · Cited by 76 · see citing works
Linear motifs confer functional diversity onto splice variants
Weatheritt, R. J., Davey, N. E., & Gibson, T. J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks442 · Cited by 76 · see citing works
Pfoh, R., Lacdao, I. K., Georges, A. A., Capar, A., Zheng, H. X., Frappier, L., & Saridakis, V. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004950 · Cited by 72 · see citing works
Self-citationA role for USP7 in DNA replication.
Jagannathan, M., Nguyen, T., Gallo, D., Luthra, N., Brown, G. W., Saridakis, V., & Frappier, L. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00639-13 · Cited by 71 · see citing works
Self-citationRuano, Y., Mollejo, M., Camacho, F. I., de Lope, Á. R., Fiaño, C., Ribalta, T., Martínez, P., Hernández-Moneo, J.-L., & Meléndez, B. (2008) · Cancer · doi:10.1002/cncr.23338 · Cited by 71 · see citing works
Regulation of the DNA damage response by ubiquitin conjugation
Brinkmann, K., Schell, M. J., Hoppe, T., & Kashkar, H. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00098 · Cited by 70 · see citing works
Deubiquitination in virus infection
Lindner, H. A. (2007) · Virology · doi:10.1016/j.virol.2006.12.035 · Cited by 69 · see citing works
Ma, J., Martin, J. D., Xue, Y., Lor, L. A., Kennedy-Wilson, K. M., Sinnamon, R. H., Ho, T. F., Zhang, G., Schwartz, B. K., Tummino, P. J., et al. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.08.020 · Cited by 67 · see citing works
Genome-wide interrogation of gene functions through base editor screens empowered by barcoded sgRNAs
Xu, P., Liu, Z., Liu, Y., Ma, H., Xu, Y., Bao, Y., Zhu, S., Cao, Z., Wu, Z., Zhou, Z. L., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-00944-1 · Cited by 66 · see citing works
The role of UBL domains in ubiquitin-specific proteases
Faesen, A. C., Luna‐Vargas, M. P. A., & Sixma, T. K. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120004 · Cited by 66 · see citing works
Jäger, W., Santag, S., Weidner-Glunde, M., Gellermann, E., Kati, S., Pietrek, M., Viejo‐Borbolla, A., & Schulz, T. F. (2012) · Journal of Virology · doi:10.1128/jvi.06840-11 · Cited by 65 · see citing works
A role of HAUSP in tumor suppression in a human colon carcinoma xenograft model.
Becker, K., Marchenko, N., Palacios, G., & Moll, U. M. (2008) · Cell Cycle · doi:10.4161/cc.7.9.5756 · Cited by 63 · see citing works
Tong, X., Buelow, K. L., Guha, A., Rausch, R., & Yin, L. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.340786 · Cited by 63 · see citing works
Identification and Characterization of USP7 Targets in Cancer Cells
Georges, A. A., Marcon, E., Greenblatt, J. F., & Frappier, L. (2018) · Scientific Reports · doi:10.1038/s41598-018-34197-x · Cited by 63 · see citing works
Self-citationPHD3 Regulates p53 Protein Stability by Hydroxylating Proline 359
Rodríguez, J., Herrero, A., Li, S., Rauch, N., Quintanilla, A., Wynne, K. J., Krstić, A., Acosta, J. C., Taylor, C. T., Schlisio, S., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.108 · Cited by 62 · see citing works
Sarkari, F., Wang, X., Nguyen, T., & Frappier, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016598 · Cited by 59 · see citing works
Self-citationUSP7 Cooperates with SCML2 To Regulate the Activity of PRC1
Lecona, E., Narendra, V. K., & Reinberg, D. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.01197-14 · Cited by 59 · see citing works
Gene expression control by protein deubiquitinases
Frappier, L., & Verrijzer, C. P. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2011.02.005 · Cited by 58 · see citing works
Self-citationThe USP7 protein interaction network and its roles in tumorigenesis
Al-Eidan, A., Wang, Y., Skipp, P., & Ewing, R. M. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2020.10.004 · Cited by 57 · see citing works
Latent membrane protein 1 of Epstein-Barr virus regulates p53 phosphorylation through MAP kinases
Li, L., Guo, L., Tao, Y., Zhou, S., Wang, Z., Luo, W., Hu, D., Li, Z., Xiao, L., Tang, M., et al. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.04.014 · Cited by 57 · see citing works
Cracking the Ubiquitin Code: The Ubiquitin Toolbox
Mulder, M. P. C., Witting, K. F., & Ovaa, H. (2019) · Current Issues in Molecular Biology · doi:10.21775/cimb.037.001 · Cited by 57 · see citing works
Kim, R. Q., van Dijk, W. J., & Sixma, T. K. (2016) · Journal of Structural Biology · doi:10.1016/j.jsb.2016.05.005 · Cited by 56 · see citing works
USP7‐TRIM27 axis negatively modulates antiviral type I IFN signaling
Cai, J., Chen, H., Peng, S., Meng, J., Wang, Y., Zhou, Y. J., Qian, X., Sun, X., Pang, X., Zhang, Y., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201700473rr · Cited by 55 · see citing works
Sarkari, F., La Delfa, A., Arrowsmith, C. H., Frappier, L., Sheng, Y., & Saridakis, V. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.08.017 · Cited by 54 · see citing works
Self-citationMungamuri, S. K., Qiao, R. F., Yao, S., Manfredi, J. J., Gu, W., & Aaronson, S. A. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.049 · Cited by 54 · see citing works
The ISG15-specific protease USP18 regulates stability of PTEN
Mustachio, L. M., Kawakami, M., Lu, Y., Rodriguez‐Canales, J., Mino, B., Behrens, C., Wistuba, I. I., Bota‐Rabassedas, N., Yu, J. Q., Lee, J. J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13914 · Cited by 54 · see citing works
USP7 deubiquitinase controls HIV-1 production by stabilizing Tat protein
Ali, A., Raja, R., Farooqui, S. R., Ahmad, S., & Banerjea, A. C. (2017) · Biochemical Journal · doi:10.1042/bcj20160304 · Cited by 54 · see citing works
Nuclear deubiquitination in the spotlight: the multifaceted nature of USP7 biology in disease
Rawat, R., Starczynowski, D. T., & Ntziachristos, P. (2019) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2019.02.008 · Cited by 53 · see citing works
Insights into the ubiquitin-proteasome system of human embryonic stem cells
Sáez, I., Koyuncu, S., Gutiérrez-García, R., Dieterich, C., & Vı́lchez, D. (2018) · Scientific Reports · doi:10.1038/s41598-018-22384-9 · Cited by 52 · see citing works
Role of Deubiquitinases in Human Cancers: Potential Targeted Therapy
Lai, K. P., Chen, J., & Tse, W. K. F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072548 · Cited by 51 · see citing works
Liu, G., Liang, J., Lou, L., Tian, M., Zhang, X.-Y., Liu, L., Zhao, Q., Xia, R., Wu, Y., Xie, Q., et al. (2022) · Science Advances · doi:10.1126/sciadv.abl5765 · Cited by 49 · see citing works
Evolutionarily conserved regulators of tau identify targets for new therapies
Kim, J., de Haro, M., Al‐Ramahi, I., Garaicoechea, L. L., Jeong, H.-H., Sonn, J. Y., Tadros, B., Liu, Z., Botas, J., & Zoghbi, H. Y. (2023) · Neuron · doi:10.1016/j.neuron.2022.12.012 · Cited by 49 · see citing works
Harper, S. J., Gratton, H. E., Cornaciu, I., Oberer, M., Scott, D. J., Emsley, J., & Dreveny, I. (2014) · Biochemistry · doi:10.1021/bi500116x · Cited by 49 · see citing works
- Authors
- Sheng, Y., Saridakis, V., Sarkari, F., Duan, S., Wu, T., Arrowsmith, C. H., & Frappier, L.
- Affiliations
- University of Toronto (CA)
- Corresponding author
- Frappier, Lori
- Venue
- Nature Structural & Molecular Biology
- Published
- 2006-02-12
- Volume
- 13
- Issue
- 3
- Pages
- 285-291
- ISSN
- 1545-9985 (ISSN-L)
- 1545-9993
- OpenAlex
- W2032610349
- Cited by
- 315
- References
- 19
- Citations by year
- 2026: 19 · 2025: 24 · 2024: 16 · 2023: 20 · 2022: 21 · 2021: 19 · 2020: 22 · 2019: 25 · 2018: 14 · 2017: 11 · 2016: 16 · 2015: 22 · 2014: 10 · 2013: 13 · 2012: 10
- FWCI
- 4.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Structural & Molecular Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Terry Fox Foundation
- Natural Sciences and Engineering Research Council of Canada
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Keywords
- USP7, p53, MDM2, ubiquitin-specific protease, protein-protein interaction, substrate recognition, peptide binding, co-crystal structure, p53 stabilization, serine residues
- MeSH terms
- Ubiquitin-Specific Peptidase 7, Amino Acid Sequence, Binding Sites, Humans, Models, Molecular, Molecular Sequence Data, Mutation, Endopeptidases, Peptides, Protein Binding, Protein Conformation, Tumor Suppressor Protein p53, Protein Structure, Tertiary, Crystallography, X-Ray, Amino Acid Motifs, Protein Interaction Mapping, Ubiquitin Thiolesterase, Proto-Oncogene Proteins c-mdm2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review